Structurally distinct cyclosporin and sanglifehrin analogs CRV431 and NV556 suppress established HCV infection in humanized-liver mice

Michael Bobardt(Scripps Research Institute), Philippe Gallay(Scripps Research Institute), Magnus J. Hansson(Medicon Village), Patrick Mayo(Scripps Research Institute), Robert T. Foster(Edison Pharmaceuticals (United States)), Daren Ure(NAEJA-RGM Pharmaceuticals (Canada))
PLoS ONE
August 7, 2020
Cited by 15


Related Papers